| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Roivant Sciences Ltd. (ROIV) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 18 sells. ROIV is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 113.32M | $3.54B | - | |
| 10% | 33.65M | $1.05B | - | |
| Pres | 18.68M | $583.68M | - | |
| CEO | 16.74M | $523.00M | - | |
| Dir | 15.35M | $479.76M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 23, 2023 | Venker Eric | President &COO | Sale+OE | 415 | $9.85 | $4,087.75 | - | +16.7% | +20.2% | |
| May 9, 2023 | Venker Eric | President &COO | Sale+OE | 238,724 | $9.23 | $2,203,422.52 | -26.1% | +20.0% | +19.6% | |
| May 8, 2023 | Venker Eric | President &COO | Sale+OE | 150,044 | $8.56 | $1,283,924.98 | -10.0% | +25.4% | +27.0% | |
| May 3, 2023 | Venker Eric | President &COO | Sale+OE | 288,989 | $8.40 | $2,427,128.91 | -12.5% | +41.4% | +33.2% | |
| May 2, 2023 | Kumar Rakhi45 | Chief Accounting Officer | Sale+OE | 77,736 | $8.55 | $664,492.16 | -16.3% | +45.9% | +36.5% | |
| Apr 28, 2023 | Venker Eric | President &COO | Sale+OE | 222,243 | $8.55 | $1,899,190.91 | -9.9% | +26.3% | +29.0% | |
| Apr 28, 2023 | Kumar Rakhi45 | Chief Accounting Officer | Sale+OE | 230,788 | $8.56 | $1,976,057.42 | -27.8% | +26.3% | +29.0% | |
| Mar 20, 2023 | Svf Investments (uk) Ltd57 | 10% Owner | Sell | 12,000,000 | $8.00 | $96,000,000.00 | -12.6% | +12.4% | +14.0% | |
| Mar 1, 2023 | Pulik Richard | CFO | Sell | 1,912 | $8.08 | $15,448.96 | -0.8% | +14.5% | +44.4% | |
| Feb 22, 2023 | Ramaswamy Vivek | Director | Sell | 4,000,000 | $7.95 | $31,800,000.00 | -6.8% | +14.7% | +38.7% |